Delirium after interleukin-2 and alpha-interferon therapy for renal cell carcinoma

被引：0
作者：
Van Steijn, JHM [1 ]
Nieboer, P [1 ]
Hospers, GAP [1 ]
De Vries, EGE [1 ]
Mulder, NH [1 ]
机构：
[1] Univ Groningen Hosp, Dept Med Oncol, Groningen, Netherlands
来源：
ANTICANCER RESEARCH | 2001年 / 21卷 / 05期
关键词：
alpha-nterferon; central nervous svstem; interleukin-2; renal cell carcinoma;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A 55-year-old man receiving alpha-interferon and interieukin-2 therapy for renal cell carcinoma presented with seizures and delirium. A CT-scan of the cerebrum did not reveal any disorder. Both alpha-interferon and interleukin-2 were stopped Treatment with steroids led to complete regression of central nervous system symptomatology. We emphasize the importance of ruling out iatrogenesis in patients treated with alpha-interferon and/or interleukin-2 who display neuropsychiatric symptoms.
引用
收藏
页码：3699 / 3700
页数：2
相关论文
共 50 条
  • [21] Complete remission of pulmonary metastasized renal cell carcinoma after inhalative interleukin-2 therapy
    Rohrmann, K
    Schleypen, J
    Adam, C
    Hofstetter, A
    Siebels, M
    UROLOGE A, 2004, 43 (10): : 1271 - 1274
  • [22] Symptomatic neurological epidural metastasis with interleukin-2 therapy in metastatic renal cell carcinoma
    Trufflandier, N
    Gille, O
    Palussière, J
    Prié, L
    Pointillart, V
    Ravaud, A
    TUMORI, 2002, 88 (04) : 338 - 340
  • [23] IMMUNOTHERAPY WITH INTERLEUKIN-2 AND ALPHA-INTERFERON IN PATIENTS WITH METASTATIC RENAL-CELL CANCER WITH INSITU PRIMARY CANCERS - A PILOT-STUDY
    SPENCER, WF
    LINEHAN, WM
    WALTHER, MM
    HAAS, GP
    LOTZE, MT
    TOPALIAN, SL
    YANG, JC
    MERINO, MJ
    LANGE, JR
    POCKAJ, BA
    ROSENBERG, SA
    JOURNAL OF UROLOGY, 1992, 147 (01) : 24 - 30
  • [24] Phase II trial of interleukin-2 and interferon-alpha in patients with renal cell carcinoma: Clinical results and immunologic correlates of response
    Bukowski, RM
    Olencki, T
    Wang, Q
    Peereboom, D
    Budd, GT
    Elson, P
    Sandstrom, K
    Tuason, L
    Rayman, P
    Tubbs, R
    McLain, D
    Klein, E
    Novick, A
    Finke, J
    JOURNAL OF IMMUNOTHERAPY, 1997, 20 (04) : 301 - 311
  • [25] Progressive anemia following combination therapy with interferon-α and interleukin-2 in a patient with metastatic renal cell carcinoma
    Hosokawa, Y
    Kishino, T
    Ono, T
    Oyama, N
    Hayashi, K
    Momose, H
    INTERNATIONAL JOURNAL OF UROLOGY, 2004, 11 (10) : 906 - 908
  • [26] Maintenance biotherapy with interleukin-2 and interferon for metastatic renal cell cancer
    Porta, Camillo
    EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (01) : 141 - 152
  • [27] Immunochemotherapy for metastatic renal cell carcinoma using a regimen of interleukin-2, interferon-alpha and 5-fluorouracil
    Hofmockel, G
    Langer, W
    Theiss, M
    Gruss, A
    Frohmuller, HGW
    JOURNAL OF UROLOGY, 1996, 156 (01) : 18 - 21
  • [28] Linomide and interleukin-2 in patients with advanced renal cell carcinoma
    Deckert, M
    Franzke, A
    Buer, J
    Probst, M
    Duensing, S
    LopezHaenninen, E
    Kirchner, H
    Poliwoda, H
    Atzpodien, J
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 1996, 11 (05) : 319 - 324
  • [29] Inhaled interleukin-2 therapy in pulmonary metastatic renal cell carcinoma: Six years of experience
    Huland, E
    Heinzer, H
    Mir, TS
    Huland, H
    CANCER JOURNAL FROM SCIENTIFIC AMERICAN, 1997, 3 : S98 - S105
  • [30] Phase II study of interferon-gamma versus interleukin-2 and interferon-alpha 2b in metastatic renal cell carcinoma
    Lummen, G
    Goepel, M
    Mollhoff, S
    Hinke, A
    Otto, T
    Rubben, H
    JOURNAL OF UROLOGY, 1996, 155 (02) : 455 - 458
12345